您好,欢迎来到化工原料网! [登录] [免费注册]
化工原料网
位置:首页 > 产品库 > Rabeprazole-d4(sodium salt)
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
Rabeprazole-d4(sodium salt)
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
Rabeprazole-d4(sodium salt)图片
规格:98%
分子量:385.4
包装与价格:
包装价格(元)
500ug电议
1mg电议

产品介绍
A neuropeptide with diverse biological activities
货号:ajcx23384
CAS:N/A
分子式:C18H16D4N3O3S.Na
分子量:385.4
溶解度:DMF: 30 mg/ml,DMSO: 25 mg/ml,Ethanol: 30 mg/ml,PBS (pH 7.2): 10 mg/ml
纯度:98%
存储:Store at -20°C
库存:现货

Background:

Rabeprazole-d4is intended for use as an internal standard for the quantification of rabeprazole by GC- or LC-MS. Rabeprazole is a proton pump inhibitor that selectively and irreversibly inhibits the gastric H+/K+ATPase (IC50= 72 nM).1It can be activated more rapidly and over a greater pH range than other proton pump inhibitors such as omeprazole , lansoprazole , and pantoprazole .2Rabeprazole (30 mg/kg) inhibits gastric acid secretion in pylorus-ligated rats and a rat model of gastric fistula.3It also inhibits the growth of several strains ofH. pylori in vitro(MIC50s = 1.57-3.13 μg/mL).2Formulations containing rabeprazole have been used in the treatment of ulcers, pathological hypersecretory conditions, and gastroesophageal reflux disease (GERD).


1.Morii, M., Takata, H., Fujisaki, H., et al.The potency of substituted benzimidazoles such as E3810, omeprazole, Ro 18-5364 to inhibit gastric H+,K+-ATPase is correlated with the rate of acid-activation of the inhibitorBiochemical Pharmacology39(4)661-667(1990) 2.Williams, M.P., and Pounder, R.E.Review article: The pharmacology of rabeprazoleAlimentary Pharmacology and Therapeutics13(3)3-10(1999) 3.Tomiyama, Y., Morii, M., and Takeguchi, N.Specific proton pump inhibitors E3810 and lansoprazole affect the recovery process of gastric secretion in rats differentlyBiochem. Pharmacol.48(11)2049-2055(1994)